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There has been no previous study to classify breast cancers in detail based on histopathologically confirmed diagnosis in 
Abia State University Teaching Hospital, Aba, Nigeria. This study aims at determining the prevalence and histological 
pattern of breast cancers in our centre. This retrospective study was based on histopathological diagnosed breast cancer 
lesions from January 2012 to December 2016. Out of 305 archival results and slides retrieved, 29.8% were cancerous in 
nature. The ratio of benign to malignant lesion was 2.35:1. The age range of the patients was 21-71years. The peak 
incidence age range was the fifth decade (50, 54.94%). Mean age of breast cancer patients was 46.5+5.4years while 
majority of patients (78.0%) were in s age group of 21-50years. The left breast (61.5%) was more affected than the right. 
Invasive ductal carcinoma was the predominant histologic presentation (72.52%), followed by invasive lobular carcinoma 
(10.98%) and metastatic carcinoma (4.40%). Nineteen (21%) of the patients presented with stages 1 and 11 of the disease 
while majority 72 (79.1%) presented with advanced stage of disease commonly with stage 111. There was no significant 
relationship between clinical stage of breast cancer and the age of patients seen (p value >0.05). 
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INTRODUCTION   
 
Breast cancer is the most common and lethal malignancy in developing countries with varying presentations (Kene et al., 
2010). It is the commonest female malignancy globally, having overtaken cervical cancer as the leading female malignancy 
(Balekouzou et al., 2016, Forbes, 1997, Salanke and Adebamowo, 1996). Currently, it is the most leading cause of cancer 
death with 198,000 deaths per annum which represents 15.4% of all death in developed regions after that of lungs cancer 
(Ly et al., 2011). In developing countries, it is the first leading cause of death among women with 324, 000 deaths which 
represents 14.3% of all deaths (Ly et al., 2011; Elgaili et al., 2010). Moreover, this rate varied from 6 to 20 per 100,000 in 
East Asia and West Africa as a whole (Balekouzu et al., 2016, Ferlay et al., 2013). 
 
The burden of the disease caused by breast cancer is enormous and the etiology is far from being fully understood; though 
large differences have been observed in the behaviour of the tumuor, clinical manifestation, treatment response and 
prognosis (Balekouzu et al, 2016; Wen et al, 2015). Research has shown that breast cancer risk is increased in patients with 
atypical ductal and atypical lobular hyperplesia (Dupont et al, 2006; Hartmann et al, 2005; Jensen et al, 1989). Researchers 
have also reported a relative risk of 3.1 for subsequent breast cancer in women with atypical lobular hyperplesia (Dupont et 
al., 2006).  
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Furthermore, a four to five fold increased risk for breast cancer has been associated with atypical ductal hyperplesia mostly 
in the ipsilateral breast within 10-15years of diagnosis (Hartmann et al, 2005). Other researchers equally have placed the 
relative risk of invasive cancer development at 1.3 to 1.9 for proliferative breast disease without atypia (Palli et al, 1991, 
Dupont et al., 1985, Uwaezuoke and Udoye, 2014). 
 
The mortality rate of breast cancer varies proportionally with age, stage of disease at diagnosis, the speed of management, 
type and extent of the tumor and response to initial treatment (Balekouzou et al., 2016). The main risk factors related to 
breast cancer are hormonal factors related to pre-meno pausal estrogenic impregnation, genetic predisposition and 
environmental factors (Majeed et al., 2014). The African breast cancer patient is likely to present with more aggressive 
tumor than her Western counterpart and is likely to die from the disease (Gakwaya et al., 2008).  
 
In Nigeria as in most developing countries, late presentations with unfavorable prognosis are common (Gukas et al., 2005; 
Gakwaya et al., 2005). Researchers believe that the poor prognostic features of tumours of African origin are only 
reflections of the late stage at diagnosis, non-availability of screening methods and the adverse influence of lack of 
awareness of the disease and some other epidemiological risk factors (Adebamowo et al., 2008; Awadelkarim et al., 2008). 
The burden of management of breast cancer in a resource limited country like Nigeria weighs heavily on the patients who 
are likely to be poor, illiterate and has no form of health insurance. The patients is therefore forced to seek cheaper 
alternative treatment elsewhere and only come to hospital as a last resort with an advanced stage of the diseased (Agbo et 
al., 2014). 
 
Breast cancer is recognized as a major public health problem in developing countries and the prevalence of non-
communicable disease especially cancer is on the increase (Lucas and Gilles, 2003). There is paucity of information of this 
group of disease in this centre. The aim of this study was to determine the prevalence and characterize the histopathological 
pattern of breast cancer in the Abia State University Teaching Hospital, Aba, Nigeria. 
 
MATERIALS AND METHODS             
 
Study area/Setting: Study was carried out at the histopathology department of the Abia State University Teaching 
Hospital between 1st January 2012 and 31st December 2016. 
 
Ethical consideration: Ethical approval was obtained from ethical committee of Abia State University Teaching Hospital, 
Aba. 
 
Sample collection and sample analysis: All the original request forms and histopathological reports on the breast 
specimens received within this study period at the histopathology department with their slides were retrieved from the 
archives and reviewed. The cases of breast cancer formed the focus of this restrospective study. From the request forms, 
histopathological reports and surgical day books of the department, clinical and demographic data regarding age, sex, 
nature of specimen, stage of disease, hospital numbers and laboratory numbers were extracted. New slides were made from 
formalin fixed, paraffin-embedded tissue blocks and stained with Haematoxylin and Eosin (H &E) where necessary for 
appropriate diagnosis and classification. Cases of breast lesions with incomplete data and cases of which we were unable to 
trace their slides or blocks were excluded from study. 
 
Statistical analysis:  Data analyses were done using statistical package for social sciences (SPSS version 16). Comparison 
of mean was done using the students-t-test. The level of statistical significance was taken as p<0.05. 
 
RESULTS   
 
Out of 305 histopathologically diagnosed breast lesions, 91(29.80%) were cancerous in nature. The ratio of benign to 
malignant lesions was 2.35:1. Table 1 shows the age distribution of breast cancers seen in this study. The age range of 
breast cancer was 21-71years while the peak incidence age range was the fifth decade of life (50, 54.94%). The mean age 
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Table 1: Age distribution of breast carcinoma 
 
Age in years     11-20 21-30 31-40 41-50 51-60 61-70 71-80 
Invasive ductal carcinoma   - - - 17 37 10 2 
Invasive lobular carcinoma - 3                  - 4 3 - 
Metastatic carcinoma - - 1 3 - - - 
Medultary carcinoma - - - 3 - - - 
Papillary carcinoma - - - - - 3 - 
Mucinous adenocarcinoma   - - - - 2 - - 
Inflammatory carcinoma - - 1 - - - 1 
Colloid carcinoma - - - - - - 1 
Malignant phyllodes - - 1 - - - - 
 
 
The cancers affected mostly the left breast 56 (61.5%). The upper outer quadrant of the breast 51(56.0%) was mostly 
involved followed by the areola region in 27 (29.7%) of patients. Only 8 (8.7%) had the whole breast involved and there 
was no bilateral involvement at presentation. 
 
Invasive ductal carcinoma was the predominant histologic presentation 66 (72.52%). This was followed by invasive lobular 
carcinoma 10(10.98%) and metastatic carcinoma 4(4.40%). 
 
 
Table 2: Frequently distribution of histologic type of tumor 
 
TUMOUR HISTOLOGY                           FREQUENCY PERCENTAGE 
Invasive Ductal carcinoma 66 72.52 
Invasive lobular carcinoma                10 10.98 
Metastatic carcinoma                         4 4.40 
Medullary carcinoma                         3 3.30 
Papillary carcinoma                           3 3.30 
Mucinuous adenocarcinoma                2 2.20 
Inflammatory carcinoma                    1 1.10 
Colloid carcinoma                             1 1.10 
Malignant phyllodes                          1 1.10 
Total                    91 100 
 
Nineteen (21%) of the patients presented with stages 1 and 2 of the disease. Majority of the patients 72 (79.1%) presented 
with advanced stage of disease, commonly with Manchester stage 3.  Majority of the breast cancer patients 72(79.1%) were 
premenopausal. There was no significant relationship between the clinical stage of breast cancer and the age of patients 
seen (P value > 0.05) (Table 3). 
 
 
Table 3: Association between breast cancer stage and age of patients. 
  
AGE IN YEARS               STAGES 1-2              STAGES 3-4           P VALUE 
 N (%) N (%)  
≤50                           14(19.7)                 57(80.3)              >0.05 
≤50                           5 15 (75.0)  
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The burden of the disease caused by breast cancer is enormous, being the most common female malignancy globally 
(Balekouzou et al., 2016). It is therefore a major public health concern. In this study, breast cancer constituted 29.80% (91) 
of all breast diseases seen while benign breast disease was 70.20% (214). The benign: malignant (B:M) ratio of 2.35:1 in 
this study is consistent with studies in Kano, Nigeria with a B:M ratio of 2.6:1 (Ochicha et al., 2002). This is in contrast to 
studies in Sokoto and Gombe, Nigeria where the B:M ratio of 1.2:1 and 1.4:1 were reported respectively (Agbo et al; 2014; 
Mayun et al, 2008). Similar findings in other studies in Nigeria show breast cancer to constitute 28.8%, 27.5% and 31.20 of 
all breast diseases in Warri, Benin and Enugu respectively (Forae et al., 2014; Olu-Eddo and Ugiegbe, 2011; Anyikam et 
al., 2008). 
 
The mean age of the breast cancer patients was 46.5± 5.4 years, while the majority of the patients 72 (79.1%) were 
premenopausal in the age group of 21-50 years. This is similar to the findings of 69.0% reported in Nnewi, Eastern Nigeria 
(Anyanwu, 2000) and 77.3% in Zaria (Odigie et al., 2003). This study therefore shows that breast cancer occurs in younger 
age among our women than in Western countries (Anyanwu, 2000). Most published studies in Nigeria and America reveal 
that breast cancer in African women occur about a decade earlier than their Western counter parts (Anyanwu, 2000; 
Adebamowo and Adekunle, 1999; Joslyn, 2000). African American women also present at much younger age than their 
Caucasian counter parts (Elmore et al., 1998; Gao et al., 1997). Also black British women present at significantly younger 
age (median age of 46 years) than white patients with median age of 67 years (Bowen et al., 2008). The reasons for this 
early age of onset of breast cancer among black women are poorly understood but could probably be connected to the 
aggressive nature of the disease and the mutations in the breast cancer genes (BRCA 1 and 2) and their variants 
(Chlebowski et al., 2005; Gao et al., 1997). 
 
The predominant histologic type of invasive ductal carcinoma (72.52%) in this study is not different from other findings in 
Nigeria and elsewhere (Anyanwu, 2000; Ntekim et al., 2009; Kakarala et al., 2010). This was followed by invasive lobular 
carcinoma (10.98%). The left breast was mostly affected 56 (61.5%) with the upper outer guardant mostly involved 51 
(56.0%) either singly or in combination with other parts of the breast. This is similar to the results reported by 
Adesunkanmi et al., at Ile-Ife, Nigeria (2006).The upper outer quadrant is also reported to be more commonly involved in 
African and European studies (Badoe et al., 2000; Odigie et al., 2003; Mann et al., 1999). This may probably be due to the 
association of the upper outer quadrant with the axillary tail which is a channel for drainage of lymph to the axillary lymph 
nodes and may carry micro-metastasis more than the other quadrants of the breast (Kene et al., 2010). 
 
The majority of the patients in this study (79.1%) presented with the advanced stage of the disease, commonly in 
Manchester stage 3. This finding is similar to several studies in Nigeria (Odigie et al., 2003; Anyanwu, 2000; Hassan et al., 
1992; Adesunkanmi et al., 2006). Ohene – Yeboah and Adjei (2012) in Kumasi, Ghana reported that 85.2% (281) of 
patients presented with stages 3 and 4 of the disease and 82.1% (271) were invasive. These findings confirm that breast 
cancer in African women is characterized by a younger age at onset, advanced stage at diagnosis and poor prognosis. 
Studies by Sharma et al (2012), concluded that poverty and lower education level were the major causes of delay in 
presentation. Other reasons for late presentation of patients in hospitals include lack of information and awareness about 
breast cancer, ignorance of the disease symptoms, cultural beliefs, skeptical attitude towards Western medicine, fear of the 
consequences, resort to cheaper alternative treatment like herbal, traditional or faith healing. (Mbuka – Ongona and 
Tumbso, 2013; Otieno et al., 2010).  
 
Other reasons include low socioeconomic level of the patients, lack of access to quality health care and lack of an effective 
national program for screening breast cancer (Balekouzou et al., 2016; Agbo et al., 2014). It is also observed that there is 
no significant relationship between the clinical stage of breast cancer and the age of patient. 
 
CONCLUSION   
 
Breast cancer in our environment affects younger women, presents late and tends to run an aggressive course. Public health 
education and advocacy must be sustained to bring about positive change and improve outcome. Well-funded and 
dedicated breast cancer screening and treatment centers should be set up within reach for early detection, treatment and 
follow up of atypical lesions thereby reducing the chances of progression of these lesions to invasive cancer. 
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